WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Mondelez International (MDLZ) Stock Analysis

HOLD

MDLZ Equity Research — HOLD — July 2026

← KOMO →

Rating date

Jul 20, 2026

21 days ago

Desk view

HOLD

5D move

—

Neutral (HOLD unscored)

Peer rank

61p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · MDLZ

Here is the equity note on MDLZ (Mondelez International).

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

  • Short-term trend is improving — price has rallied off the June 30 low (~$57.84) and is now above both the 50-day and 200-day SMAs, a rare positive alignment after months of trading below them.
  • Momentum is healing but not yet confirmed bullish — MACD is still negative, though narrowing rapidly. A bullish MACD crossover in the coming days would reinforce the recovery narrative.
  • RSI at neutral — no overbought/oversold extremes, giving the stock room to extend gains or pull back without triggering technical alarms.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

MDLZ Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

25 min read

WebserviceX · Agentic Research Desk

MDLZ Equity Research Note

Published Jul 20, 2026 · Desk view HOLD · Generated 2026-07-21T15:43:40Z · Maintained by Walter Vijayakumar · Methodology · Track record

MDLZ Stock Rating Summary

MDLZ bias

HOLD

Horizon

Short to medium term

MDLZ key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

MDLZ catalyst watch

Short-term trend is improving — price has rallied off the June 30 low (~$57.84) and is now above both the 50-day and 200-day SMAs, a rare positive alignment after months of trading below them.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Neutral (HOLD unscored)Peer 61p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:29.634403+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+0.68%

Vol (20D ann.)

+31.95%

vs SPY: +1.63%

Close 60.27 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · MDLZ

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace c8185f90…

No QC issues recorded.